Search

You searched for "AMN"

1308 results found

Brolucizumab in age-related macular degeneration, HAWK Study

3 October 2023 | | EYE - Vitreo-Retinal | Neovascular age-related macular degeneration, aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, commercial formulation
The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

WVUK (Women in Vision) Winter Meeting 2023

12 December 2023
December 2, 2022, brought together Women in Vision UK (WVUK) members for their winter meeting. WVUK is a membership organisation focussed on gender equality in vision-related sciences and healthcare. This year’s winter meeting was held in Moorfields Education Hub and...

The VISION 2020 LINKS Programme: Cascading leadership training in Calabar, Nigeria

1 October 2016 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme has initiated ‘LEAD FORWARD’, an innovative leadership development project incorporating a commitment to cascade training and participate in achievable quality or service improvement projects. The project provides opportunities to apply leadership skills in practice as...

Sharing best practice and landmark evidence in glaucoma care

1 August 2019 | | EYE - Glaucoma, EYE - General
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...

7th Anterior Segment Meeting

8 November 2024
A day of ophthalmic education with a range of interesting talks focusing on topics within Corneal, Oculoplastic, Glaucoma and Debates.Chairs: Mr Mario Saldanha & Mrs Anjana Haridas | Singleton Hospital) & Mrs. Anjana Haridas -University of Wales

Childhood glaucoma

2 October 2025 | | EYE - Paediatrics, EYE - Glaucoma
When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This previously published article (2019) outlines the knowledge, techniques and approaches that offer...

What's trending Oct/Nov 2019

1 October 2019 | | EYE - Vitreo-Retinal, EYE - General
#probeyeotic #eyeballbugs #microbiome The human microbiome usually conjures up images of the gastrointestinal tract and yoghurt containing good bacteria. However, research suggests that the ocular mucosa is home to a unique microbe collection, with important immunological functional properties [1]. This...

On Retina UK's behalf... Grant Call - Application Deadline Extension

9 April 2025 | funding, opportunities, application, retina, genetics, research
Further to their letter of November 2024, Retina UK is extending the deadline for expressions of interest / preliminary applications to their first grant call for an award of up to £1 million. The call forms a key element of...

Update on emerging therapies for age-related macular degeneration

4 December 2023 | | EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...

Cataract surgery in uveitis patients

1 February 2016 | | EYE - Cataract, EYE - Refractive
Cataract formation is a common complication of uveitis, causing up to 40% of vision loss in these patients. Cataract results from inflammation +/- corticosteroid therapy and is usually posterior subcapsular, but a small proportion have a rapid increase in nuclear...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

What's trending Dec/Jan 2020

2 December 2019 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - Glaucoma
#eyedoctor #banned #visamix-up #HomeOffice #hostileenvironment An ophthalmologist was left stranded overseas when the Home Office refused him entry due to a visa mix-up. Dr Chan was working as a fellow at Moorfields Eye Hospital until August 2019, then was offered...